Holliston

The bioengineered organ implant company Biostage has announced it will release 2.8 million shares of common stock in an effort to raise $5 million.

Biostage announced that it has successfully regenerated a complete section of esophagus in a large-animal study, with the results having implications for the treatment of cancer and other illnesses.

A new facility launched by Web Industries is looking to expand the availability of quick diagnostic tests.

A 35,500 square foot leasing spree at the New England Industrial Park in Holliston has just been completed in four separate transactions.

Central Massachusetts companies from Worcester to Milford and over to Framingham have pledged to grow their businesses by more than 120 jobs in exchange for $1.845 million in tax incentives from the Massachusetts Life Sciences Center (MLSC).

Marlborough contract manufacturer Web Industries will unveil its new 25,000-square-foot Holliston facility on Thursday.

Harvard Apparatus Regenerative Technology, Inc. has rebranded itself as Biostage, Inc. to reflect a shift in its focus to bioengineered organ implants.

LAURA MONDANO is now vice president of regulatory affairs at Harvard Apparatus Regenerative Technology in Holliston. In...

Harvard Bioscience of Holliston is investigating a possible embezzlement of less than $50,000 from a subsidiary company.

Holliston-based Harvard Apparatus Regenerative Technology (HART) announced a fourth quarter loss as it continued to drive its organ replacement technology to market through large-animal studies being done at the Mayo Clinic.